MedTrace Logo

Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation

NCT00342381 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2007-12-17

No results posted yet for this study

Summary

The purpose of this study is to investigate fatigue in patients with multiple sclerosis (MS) and to determine the correlation between the symptom and cerebral changes.

Conditions

Interventions

DRUG

3,4-diaminopyridine

Single dose 3,4 diaminopyridine

DRUG

Placebo

Single dose placebo treatment

Sponsors & Collaborators

  • The Danish Multiple Sclerosis Society

    collaborator UNKNOWN

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Henning Andersen, MD, DMSc · Aarhus University Hospital

  • Johannes Jacobsen, Professor · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-06-30
Completion
2007-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00342381 on ClinicalTrials.gov